Home  /  Resource Library  /  Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

Study examined the prognostic signifigance of double hit features combined with TP53 mutations for germinal center type DLBCL in patients treated with chemoimmunotherapy.